Triggering of lymphocyte antigen receptors is the critical first step in the adaptive immune response against pathogens. T cell receptor (TCR) ligation assembles a large membrane signalosome, culminating in NFkB activation [1, 2] . Recently, caspase-8 was found to play a surprisingly prominent role in lymphocyte activation in addition to its well-known role in apoptosis [3] . Caspase-8 is activated after TCR stimulation and nucleates a complex with B cell lymphoma 10 (BCL10), paracaspase MALT1, and the inhibitors of kB kinase (IKK) complex [4] . We now report that the ubiquitin ligase TRAF6 binds to active caspase-8 upon TCR stimulation and facilitates its movement into lipid rafts. We identified in silico two putative TRAF6 binding motifs in the caspase-8 sequence [5] and found that mutation of critical residues within these sites abolished TRAF6 binding and diminished TCR-induced NF-kB activation. Moreover, RNAi-mediated silencing of TRAF6 abrogated caspase-8 recruitment to the lipid rafts. Protein kinase Cq (PKCq), CARMA1, and BCL10 are also required for TCR-induced caspase-8 relocation, but only PKCq and BCL10 control caspase-8 activation. Our results suggest that PKCq independently controls CARMA1 phosphorylation and BCL10-dependent caspase-8 activation and unveil an essential role for TRAF6 as a critical adaptor linking these two convergent signaling events.
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Summary
Triggering of lymphocyte antigen receptors is the critical first step in the adaptive immune response against pathogens. T cell receptor (TCR) ligation assembles a large membrane signalosome, culminating in NFkB activation [1, 2] . Recently, caspase-8 was found to play a surprisingly prominent role in lymphocyte activation in addition to its well-known role in apoptosis [3] . Caspase-8 is activated after TCR stimulation and nucleates a complex with B cell lymphoma 10 (BCL10), paracaspase MALT1, and the inhibitors of kB kinase (IKK) complex [4] . We now report that the ubiquitin ligase TRAF6 binds to active caspase-8 upon TCR stimulation and facilitates its movement into lipid rafts. We identified in silico two putative TRAF6 binding motifs in the caspase-8 sequence [5] and found that mutation of critical residues within these sites abolished TRAF6 binding and diminished TCR-induced NF-kB activation. Moreover, RNAi-mediated silencing of TRAF6 abrogated caspase-8 recruitment to the lipid rafts. Protein kinase Cq (PKCq), CARMA1, and BCL10 are also required for TCR-induced caspase-8 relocation, but only PKCq and BCL10 control caspase-8 activation. Our results suggest that PKCq independently controls CARMA1 phosphorylation and BCL10-dependent caspase-8 activation and unveil an essential role for TRAF6 as a critical adaptor linking these two convergent signaling events.
Results and Discussion
To study caspase-8 and TRAF6 during TCR stimulation, we employed an assay for the in situ trapping of active caspase-8 [4, 6] . Jurkat cells were pretreated with an irreversible covalent inhibitor of active caspases (biotinconjugated valine-alanine-aspartate-fluoromethylketone, b-VAD), and active caspase-8 was isolated before and after TCR stimulation. In this approach, caspases are blocked by the inhibitor as soon as they become activated and can be precipitated and quantified [6] . b-VAD was also added to lysates 10 min after stimulation for comparison. b-VAD efficiently bound to active unprocessed caspase-8 after TCR ligation in both conditions, but more precipitation was observed in posttreated samples, suggesting that an amplification loop of caspase-8 activation may occur during TCR stimulation ( Figure 1A ). We also found that TRAF6 coprecipitated with the active fraction of caspase-8 following TCR stimulation ( Figure 1A) .
Immunoprecipitation of TRAF6 revealed that it interacts with BCL10, caspase-8, and IKKb in a stimulus-dependent manner. By contrast, deficiency in caspase-8 (I9.2 Jurkat cells) dramatically reduced TRAF6, BCL10, and IKKb association ( Figure 1B) . We inferred that active caspase-8 and TRAF6 form a complex following TCR stimulation. Moreover, caspase-8 appears to be a central nexus in this so-called activation receptor-induced signalosome (ARIS) [7] , because no association of these molecules occurs in cells lacking caspase-8 (I9.2). Using glutathione S-transferase (GST) pull-down experiments, we found that in vitro-translated TRAF6 binds to GSTcaspase-8 ( Figure 1C ), suggesting that these two molecules directly interact without additional cofactors. Caspase-8 is part of a DED-containing gene cluster located on chromosome 2q33-34, together with caspase-10 and the apoptosis inhibitor cFLIP L . Because these three molecules are structurally related, they may have arisen from duplication of a common ancestral gene [8] . We therefore tested whether caspase-10 and cFLIP L could also interact with TRAF6 when overexpressed in HEK293T. Figure 1D shows that TRAF6 efficiently precipitated caspase-8, but not caspase-10. As previously documented, we failed to detect any interaction between TRAF6 and cFLIP L ( Figure 1E ) [9] . Hence, TRAF6 binding seems to be a specific function of caspase-8.
Examination of the caspase-8 sequence revealed two putative TRAF6 binding sites, PDEADF (residues 395-400) and PAEGTW (residues 416-420), located in the NH 2 -terminal portion of the small subunit ( Figure 2A ) [5] . Interestingly, neither TRAF6 binding motif was present in the cFLIP sequence, while only the first motif occurred in caspase-10 (see Figure S1 in the Supplemental Data available with this article online), suggesting that both sites in caspase 8 may be involved in TRAF6 docking. A single substitution of the glutamic acid to an alanine residue in this consensus motif strongly diminishes TRAF6 binding capacity [5] . To test the importance of these sites for TRAF6 binding to caspase 8, we mutated both E396 and E417 into alanine residues (reported as 2EA-Casp8). Although 2EA-Casp8 and wild-type caspase-8 (wt-Casp8) were expressed at similar levels and induced comparable cell death in HeLa and Jurkat cells ( Figures S2, S3 , and S5), 2EA-Casp8 association with FLAG-TRAF6 was barely detectable when expression constructs were cotransfected in HEK293T cells ( Figures 2B and 2C ). Mutation in each individual motif only partially reduced TRAF6 binding (data not shown). We next investigated whether this mutant could functionally interfere with the ability of caspase-8 to induce NF-kB. Overexpression of 2EA-Casp8 only marginally promoted NF-kB transcriptional activity compared to wt-Casp8 ( Figure 2D ). Moreover, 2EA-Casp8 markedly *Correspondence: lenardo@nih.gov reduced TRAF6-induced NF-kB activity ( Figure 2E ). Finally, ectopic expression of 2EA-but not wt-Casp8 strongly reduced TCR-induced NF-kB activation in Jurkat cells ( Figure 2F and Figure S6 ). These results suggest that the specific interaction between TRAF6 and caspase-8 is required to convey the NF-kB signal during TCR stimulation. Also, our results indicate that 2EA-Casp8 acts as a dominant negative, probably by binding to endogenous wild-type caspase-8.
Enrichment of critical molecules in lipid raft microdomains has been recognized as an essential step for TCR signal transduction [10] . Indeed, 3-phosphoinositide-dependent-kinase 1 (PDK1) controls the accumulation of the PKCq and the membrane-associated CARMA1 protein in lipid rafts following TCR engagement [11] . There, PKCq phosphorylates CARMA1 on specific serine residues in its linker region [12, 13] . This allows the subsequent recruitment of a fraction of the cytosolic BCL10, MALT1, and IKK proteins required to transmit the NF-kB activating signal [11, [14] [15] [16] . Because caspase-8 was shown to interact with BCL10 and IKK ( Figure 1 ) [4] , we investigated whether a fraction of caspase-8 was also recruited to the lipid rafts during TCR stimulation. Isolation of detergent-insoluble lipid raft fractions showed a significant enrichment in caspase-8 along with BCL10, TRAF6, and IKKb, after TCR stimulation ( Figure 3A ). Of note, the raft fraction of BCL10 exhibited a slightly higher molecular mass, detected as a doublet. This is consistent with a posttranslational phosphorylation of BCL10 once recruited to the plasma membrane [17] . Raft association of these molecules was transient and peaked at 15-30 min following TCR stimulation in both Jurkat and primary T lymphocytes ( Figures 3B and 3C ). Cells deficient in caspase-8 exhibited reduced recruitment of IKKb and BCL10, but not TRAF6, in the lipid raft fractions ( Figure 3D and Figure S7 ).
CARMA1 is tethered by a lipid moiety to the membrane and is crucial for NF-kB induction [2] . To determine whether CARMA1 reorganization in lipid rafts was affected in the absence of caspase-8, I9.2 and A3 cells were treated with fluorescent cholera toxin (CTX), which binds to the GM1 ganglioside within the rafts. Crosslinking of CD3 triggered similar aggregation of CD3 and CARMA1 with CTX in both A3 and I9.2, suggesting that caspase-8 acts downstream or in parallel to CARMA1 ( Figure 3E and Figure S8 ). We next investigated whether knockdown of TRAF6 interfered with caspase-8 redistribution to the lipid rafts. In addition, we also treated the cells with specific siRNA to PKCq and BCL10. As reported previously [18] [19] [20] [21] , knockdown of each of these molecules drastically reduced TCR-induced NF-kB activity ( Figure 3F ). The recruitment of caspase-8 to lipid rafts was significantly reduced in the absence of TRAF6, BCL10, or PKCq upon TCR stimulation ( Figures 3G and 3H ). Finally, we tested a CARMA1-deficient Jurkat cell line (JPM50.6) [22] . We only detected PKCq accumulation in lipid rafts after TCR stimulation, while caspase-8, BCL10, TRAF6, and IKK remained in the cytosol ( Figure 3I ). In conclusion, PKCq, CARMA1, BCL10, and TRAF6 all regulate caspase-8 recruitment into lipid rafts upon TCR stimulation.
To further characterize the function of TRAF6 and BCL10 in caspase-8 oligomerization/activation, we utilized b-VAD precipitation assays to assess TCR-induced caspase-8 activation status in cells transfected with different siRNA. Interestingly, in cells depleted of TRAF6, caspase-8 was normally activated and still associated with BCL10 upon TCR ligation. In contrast, there was an almost complete abrogation of TCR-induced caspase-8 activation in cells transfected with BCL10 siRNA ( Figure 4A) . Similarly, knockdown of PKCq with two independent siRNA sequences also prevented caspase-8 activation ( Figure 4B ). Hence, PKCq and BCL10, but not TRAF6, are required for caspase-8 activation during TCR stimulation. Interestingly, RNAi-mediated silencing of these molecules had no impact on caspase-8-dependent apoptosis induced by Fas crosslinking ( Figure S9 ). Thus, these two caspase-8-activating platforms function independently in causing NF-kB activation or cell death. Finally, caspase-8 activation was not affected in the CARMA1-deficient JPM50.6 cell line ( Figure 4C ). In keeping with the data from Figure 3 , this suggests that caspase-8 is first activated in the cytosol by forming a complex with BCL10 in a PKCq-dependent manner, and then is shuttled to the lipid rafts through TRAF6 and CARMA1 ( Figure 4D ).
Taken together, these results show that caspase-8 association with TRAF6 is critical for the active protease to move into lipid rafts and propagate NF-kB signaling. Why transient enzymatic activity of caspase-8 is required for TCR-induced NF-kB is still a conundrum, with at least two possibilities [23] . It is conceivable that caspase-8 cleaves an unknown substrate, promoting NF-kB activation. In this scenario, one appealing candidate is the caspase-8 regulator cFLIP [8] . Indeed, T cells from cFLIP L -transgenic mice exhibit an enhanced proliferation when exposed to suboptimal TCR stimulation [24] , and activation triggers greater caspase-8 and NFkB activities [25] . Moreover, it was recently shown that cFLIP can be cleaved by active, full-length caspase-8 into an NH 2 -terminal p22 fragment, which strongly triggers NF-kB activity [26] . However, cFLIP involvement in TCR-induced NF-kB signaling is still controversial, as no obvious defects in TCR-induced NF-kB or ERK activation were reported in thymocytes from mice with a conditional cFLIP deletion in the T cell compartment [27, 28] . None of the known components of the signaling complex appear to be cleaved by active caspase-8 (N.B. and M.J.L., unpublished data). Alternatively, caspase-8 may assume a different conformation in its active state that enhances the binding and/or ubiquitin ligase activity of TRAF6, without cleavage of a specific substrate. Indeed, our data suggest that caspase-8 stimulation triggers an autoamplification loop, resulting in more active caspase-8 and better TRAF6 recruitment. Recently, Sun et al. identified MALT1 as a binding partner for TRAF6. Moreover, high molecular weight oligomers of BCL10 and MALT1 recruit and enhance TRAF6 ubiquitin ligase activity, culminating with NEMO ubiquitination [20] . Thus, active multimerized caspase-8 may participate with MALT1 in increasing local concentrations of TRAF6 necessary to catalyze IKK activation after TCR stimulation. Indeed, our preliminary data suggest that caspase-8 alone can also affect TRAF6-mediated NEMO ubiquitination (A.L.S., N.B., and M.J.L., unpublished data).
How external signals like TCR ligation trigger the recruitment of the cytosolic components of the ARIS to the immunological synapse remains unknown. PKCq phosphorylates CARMA1 in its linker region [12, 13] , switching CARMA1 from an inactive, closed conformation to an open conformer capable of accepting cytosolic cargo into the immunological synapse. [29] . However, these events occur at the plasma membrane and fail to explain how other cytosolic partners are recruited there. Our present results suggest that, in addition to phosphorylating CARMA1, PKCq is essential for the formation of a cytosolic complex comprising at least caspase-8, BCL10, and MALT1 through a distinct yet undetermined signal transduction event. As the proposed model illustrates (Figure 4D ), TRAF6 might function as a critical linker between this caspase-8-containing complex and phosphorylated-CARMA1 following the bifurcation of signals emanating from activated PKCq. In the future, it will be interesting to define the protein(s) linking PKCq to the nucleation of cytosolic proteins around active caspase-8. Since caspase-8 deficiency causes severe immunodeficiency in humans and experimental animals, it is clear that this mechanism plays a vital role in protective immunity [3, 4, 10] . Hence, a better understanding of the precise molecular pathway 
